Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7595397 Compounds which modulate the CB2 receptor

Patent 7595397 was granted and assigned to Boehringer Ingelheim on September, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 6 Nov, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 6 Nov, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer
0
Edits on 30 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11878985 Substituted quinazolines as inhibitors of KRAS G12C
0
Edits on 17 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 17 Sep, 2023
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
David S. Thomson0
Doris Riether0
Eugene Richard Hickey0
Innocent Mushi0
Monika Ermann0
Renee Zindell0
Edits on 16 Sep, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 16 Sep, 2023
Edits made to:
Article (+163 characters)
Article

Patent abstract

Compounds are provided which bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, the compounds having the general formula

Edits on 21 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07595397 Compounds which modulate the CB2 receptor US Patent 7595397 Compounds which modulate the CB2 receptor

Infobox
Patent Number
075953970
Patent Number
75953970
Edits on 18 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 18 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=075953970
Edits on 22 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Boehringer Ingelheim
Boehringer Ingelheim
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
075953970
Date of Patent
September 29, 2009
0
Patent Application Number
116085370
Date Filed
December 8, 2006
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=075953970
Patent Primary Examiner
‌
Rei Tsang Shiao
0
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07595397
Edits on 3 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 3 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07595397 Compounds which modulate the CB2 receptor

Infobox
Is a
Patent
Patent
Current assignee
Boehringer Ingelheim
Boehringer Ingelheim
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07595397
Date of patent
September 29, 2009
Patent application number
11608537
Date Filed
December 8, 2006
Patent primary examiner
‌
Rei Tsang Shiao

Find more entities like US Patent 7595397 Compounds which modulate the CB2 receptor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.